Insider · CIK 0001536583
Keith Murphy
Files at VIVS (VivoSim Labs, INC.), MTNB (Matinas BioPharma Holdings, Inc.). First filing -, latest -.
Keith Murphy files SEC Form 4 as director and chair at VIVS (VivoSim Labs, INC.), and also at MTNB (Matinas BioPharma Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Keith Murphy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | VIVS VivoSim Labs, INC. | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 26,053 | Jan 29, 2026 |
| Apr 30, 2025 | MTNB Matinas BioPharma Holdings, Inc. | AGrant or award Stock Option (right to Buy)derivative | +11,600 | $0.00 | $0 | 11,600 | May 2, 2025 |
Questions about Keith Murphy
Answered from the filings on this page, as of the latest one.
Is Keith Murphy buying or selling?
Keith Murphy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Keith Murphy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Keith Murphy has 0.
Where does Keith Murphy file Form 4?
Keith Murphy has filed Form 4 at VIVS (VivoSim Labs, INC.) as EXECUTIVE CHAIRMAN; MTNB (Matinas BioPharma Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.